9 Meters Biopharma Inc. Shares Close the Week 22.8% Lower - Weekly Wrap
The company saw its shares close the week 22.8% lower than last week, with trading volume higher than its 30 day average.
Mar 26, 2021 by Kwhen Finance Editors
9 Meters Biopharma Inc. shares closed this week 22.8% lower than it did at the end of last week. The stock is currently up 65.3% year-to-date, up 202.1% over the past 12 months, and down 61.4% over the past five years. This week, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.7%.
Trading Activity
- Shares traded as high as $1.86 and as low as $1.28 this week.
- Trading volume this week was 54.9% lower than the 10-day average and 46.3% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price lags the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| 9 Meters Biopharma Inc. | -1.4 | 65.3 | 202.1 | ||
| Dow Jones Industrial Average | 1.4 | 8.6 | 55.8 | -1.4 | 61.3 |
| S&P 500 Index | 1.6 | 6.3 | 58.8 | -1.5 | 62.9 |
| Health Care | 1.9 | 3.0 | 41.6 | -2.7 | 42.7 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by 44.2%
- The company's stock price performance over the past 12 months beats the peer average by 85.6%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| 9 Meters Biopharma Inc. | NMTR | 0 | 65.3 | 202.1 | ||
| Peer Avg | N/A | 0 | 45.3 | 108.9 | -13.6 | 41.0 |
| Ocular Therapeutix Inc | OCUL | 0 | -18.0 | 244.9 | ||
| OncoCyte Corp. | OCX | 0 | 98.3 | 130.1 | ||
| Oragenics Inc. | OGEN | 0 | 100.8 | 60.7 | -54.5 | 163.9 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: